CA1310903C - Diagnostic immunologique de l'infection gonococcique a l'aide d'un antigene de surface conserve de neisseria gonorrhoeae - Google Patents

Diagnostic immunologique de l'infection gonococcique a l'aide d'un antigene de surface conserve de neisseria gonorrhoeae

Info

Publication number: CA1310903C
Authority: CA; Canada
Prior art keywords: antibody; specimen; detecting; contacting; antigen
Prior art date: 1987-10-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA000580986A

Other languages

English (en)

Inventor

Peter A. Rice

L. Edward Cannon

T. Philip Wong

Wendy E. Jones

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hygeia Sciences Inc

Original Assignee

Hygeia Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-10-22

Filing date

1988-10-21

Publication date

1992-12-01

1988-10-21 Application filed by Hygeia Sciences Inc filed Critical Hygeia Sciences Inc

1992-12-01 Application granted granted Critical

1992-12-01 Publication of CA1310903C publication Critical patent/CA1310903C/fr

2009-12-01 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

241000588652 Neisseria gonorrhoeae Species 0.000 title claims abstract description 5
238000003745 diagnosis Methods 0.000 title description 7
206010018612 Gonorrhoea Diseases 0.000 title description 5
230000001900 immune effect Effects 0.000 title description 3
101710160102 Outer membrane protein B Proteins 0.000 title description 2
238000000034 method Methods 0.000 claims abstract description 31
239000000427 antigen Substances 0.000 claims abstract description 26
102000036639 antigens Human genes 0.000 claims abstract description 26
108091007433 antigens Proteins 0.000 claims abstract description 26
238000006243 chemical reaction Methods 0.000 claims abstract description 6
230000027455 binding Effects 0.000 claims abstract description 3
238000009739 binding Methods 0.000 claims abstract description 3
241000588653 Neisseria Species 0.000 claims description 12
238000003556 assay Methods 0.000 claims description 8
230000001717 pathogenic effect Effects 0.000 claims description 5
239000012530 fluid Substances 0.000 claims description 4
239000007788 liquid Substances 0.000 claims description 3
210000003800 pharynx Anatomy 0.000 claims description 3
210000003708 urethra Anatomy 0.000 claims description 3
210000004369 blood Anatomy 0.000 claims description 2
239000008280 blood Substances 0.000 claims description 2
210000003679 cervix uteri Anatomy 0.000 claims description 2
239000003599 detergent Substances 0.000 claims description 2
230000015572 biosynthetic process Effects 0.000 claims 2
230000004520 agglutination Effects 0.000 claims 1
210000002700 urine Anatomy 0.000 claims 1
238000003018 immunoassay Methods 0.000 description 22
238000012360 testing method Methods 0.000 description 13
238000001514 detection method Methods 0.000 description 10
210000004027 cell Anatomy 0.000 description 8
239000000523 sample Substances 0.000 description 7
239000012528 membrane Substances 0.000 description 6
229920001817 Agar Polymers 0.000 description 5
239000008272 agar Substances 0.000 description 5
239000000203 mixture Substances 0.000 description 5
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
230000000890 antigenic effect Effects 0.000 description 4
238000012790 confirmation Methods 0.000 description 4
239000008188 pellet Substances 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
239000006228 supernatant Substances 0.000 description 4
239000000725 suspension Substances 0.000 description 4
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
241000588655 Moraxella catarrhalis Species 0.000 description 3
241000699670 Mus sp. Species 0.000 description 3
241000588649 Neisseria lactamica Species 0.000 description 3
102000057297 Pepsin A Human genes 0.000 description 3
108090000284 Pepsin A Proteins 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
208000001786 gonorrhea Diseases 0.000 description 3
208000015181 infectious disease Diseases 0.000 description 3
239000002609 medium Substances 0.000 description 3
229940111202 pepsin Drugs 0.000 description 3
239000000243 solution Substances 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 2
241000588624 Acinetobacter calcoaceticus Species 0.000 description 2
241000222122 Candida albicans Species 0.000 description 2
241000186216 Corynebacterium Species 0.000 description 2
241000194032 Enterococcus faecalis Species 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
241000207202 Gardnerella Species 0.000 description 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
108010052285 Membrane Proteins Proteins 0.000 description 2
102000004316 Oxidoreductases Human genes 0.000 description 2
108090000854 Oxidoreductases Proteins 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
108010059712 Pronase Proteins 0.000 description 2
239000004365 Protease Substances 0.000 description 2
241000588769 Proteus <enterobacteria> Species 0.000 description 2
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
241000191967 Staphylococcus aureus Species 0.000 description 2
241000191963 Staphylococcus epidermidis Species 0.000 description 2
241000194017 Streptococcus Species 0.000 description 2
238000002835 absorbance Methods 0.000 description 2
239000012131 assay buffer Substances 0.000 description 2
229940095731 candida albicans Drugs 0.000 description 2
230000025938 carbohydrate utilization Effects 0.000 description 2
229910002092 carbon dioxide Inorganic materials 0.000 description 2
238000012136 culture method Methods 0.000 description 2
239000008367 deionised water Substances 0.000 description 2
229910021641 deionized water Inorganic materials 0.000 description 2
238000002405 diagnostic procedure Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
238000000605 extraction Methods 0.000 description 2
239000011521 glass Substances 0.000 description 2
238000000703 high-speed centrifugation Methods 0.000 description 2
210000004698 lymphocyte Anatomy 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
244000005700 microbiome Species 0.000 description 2
244000052769 pathogen Species 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
230000009257 reactivity Effects 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
229910052709 silver Inorganic materials 0.000 description 2
239000004332 silver Substances 0.000 description 2
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
238000005063 solubilization Methods 0.000 description 2
230000007928 solubilization Effects 0.000 description 2
241000894007 species Species 0.000 description 2
238000010186 staining Methods 0.000 description 2
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 2
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
206010003445 Ascites Diseases 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
229920000742 Cotton Polymers 0.000 description 1
101710088194 Dehydrogenase Proteins 0.000 description 1
201000004624 Dermatitis Diseases 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
238000003794 Gram staining Methods 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
241000588748 Klebsiella Species 0.000 description 1
241000186660 Lactobacillus Species 0.000 description 1
241001561398 Lactobacillus jensenii Species 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
201000009906 Meningitis Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
241000588651 Neisseria flavescens Species 0.000 description 1
241001136170 Neisseria subflava Species 0.000 description 1
101710116435 Outer membrane protein Proteins 0.000 description 1
101710190786 PI protein Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
206010035226 Plasma cell myeloma Diseases 0.000 description 1
241000276498 Pollachius virens Species 0.000 description 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
208000007893 Salpingitis Diseases 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
206010046443 Urethral discharge Diseases 0.000 description 1
DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
210000002255 anal canal Anatomy 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
238000003149 assay kit Methods 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003638 chemical reducing agent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000001332 colony forming effect Effects 0.000 description 1
230000001010 compromised effect Effects 0.000 description 1
210000000795 conjunctiva Anatomy 0.000 description 1
239000000470 constituent Substances 0.000 description 1
230000009260 cross reactivity Effects 0.000 description 1
238000012258 culturing Methods 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
229940061607 dibasic sodium phosphate Drugs 0.000 description 1
239000012470 diluted sample Substances 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
TVQLLNFANZSCGY-UHFFFAOYSA-N disodium;dioxido(oxo)tin Chemical compound [Na+].[Na+].[O-][Sn]([O-])=O TVQLLNFANZSCGY-UHFFFAOYSA-N 0.000 description 1
239000000975 dye Substances 0.000 description 1
206010014665 endocarditis Diseases 0.000 description 1
210000004696 endometrium Anatomy 0.000 description 1
210000000416 exudates and transudate Anatomy 0.000 description 1
239000012634 fragment Substances 0.000 description 1
239000000499 gel Substances 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
210000004754 hybrid cell Anatomy 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
238000010166 immunofluorescence Methods 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
239000003547 immunosorbent Substances 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
229940039696 lactobacillus Drugs 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
201000000050 myeloid neoplasm Diseases 0.000 description 1
210000001989 nasopharynx Anatomy 0.000 description 1
KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
229910000160 potassium phosphate Inorganic materials 0.000 description 1
235000011009 potassium phosphates Nutrition 0.000 description 1
230000008569 process Effects 0.000 description 1
239000000047 product Substances 0.000 description 1
235000013772 propylene glycol Nutrition 0.000 description 1
230000005180 public health Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000003118 sandwich ELISA Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
229940079864 sodium stannate Drugs 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000000638 solvent extraction Methods 0.000 description 1
238000011895 specific detection Methods 0.000 description 1
230000003393 splenic effect Effects 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000008399 tap water Substances 0.000 description 1
235000020679 tap water Nutrition 0.000 description 1
230000035899 viability Effects 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
238000001262 western blot Methods 0.000 description 1

Landscapes

Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

CA000580986A 1987-10-22 1988-10-21 Diagnostic immunologique de l'infection gonococcique a l'aide d'un antigene de surface conserve de neisseria gonorrhoeae Expired - Fee Related CA1310903C (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US11236687A	1987-10-22	1987-10-22
US112,366		1987-10-22

Publications (1)

Publication Number	Publication Date
CA1310903C true CA1310903C (fr)	1992-12-01

Family

ID=22343524

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000580986A Expired - Fee Related CA1310903C (fr)	1987-10-22	1988-10-21	Diagnostic immunologique de l'infection gonococcique a l'aide d'un antigene de surface conserve de neisseria gonorrhoeae

Country Status (1)

Country	Link
CA (1)	CA1310903C (fr)

1988
- 1988-10-21 CA CA000580986A patent/CA1310903C/fr not_active Expired - Fee Related

Legal Events

Date	Code	Title	Description
2001-12-03	MKLA	Lapsed

Publication	Publication Date	Title
US4497900A (en)	1985-02-05	Immunoassay for Neisseria gonorrhoeae antigens
JP3202772B2 (ja)	2001-08-27	ヘリコバクターピロリ検出用の抗原調製物
US4677055A (en)	1987-06-30	Immunological detection of bacterial pathogens with antibody-containing magnetic gel
JP2738947B2 (ja)	1998-04-08	抗原組成物およびそれらの製法および用途
US5604109A (en)	1997-02-18	Method for exposing Group A streptococcal antigens and an improved diagnostic test for the identification of Group A streptococci
Goossens et al.	1992	Evaluation of a commercially available second-generation immunoglobulin G enzyme immunoassay for detection of Helicobacter pylori infection
Jark et al.	1997	Development of an ELISA technique for serodiagnosis of bovine paratuberculosis
CA1086224A (fr)	1980-09-23	Sorbants des antigenes de neisseria meningitides pour le depistage le neisseria gonorrhoeae
US20090030054A1 (en)	2009-01-29	Cytoplasmic antigens for detection of candida
Minnich et al.	1982	Enzyme immunoassay for detection of salmonellae in foods
JP2779509B2 (ja)	1998-07-23	検出方法
Rockhill et al.	1980	Detection of Salmonella typhi D, Vi, and d antigens, by slide coagglutination, in urine from patients with typhoid fever
Parija	1998	A review of some simple immunoassays in the serodiagnosis of cystic hydatid disease
US5420014A (en)	1995-05-30	Rapid in vitro test for helicobacter pylori using saliva
AU5693399A (en)	2000-03-14	Method for detection of (legionella) bacteria employing purified antigen-specific antibodies
US8158371B2 (en)	2012-04-17	Assay for antibodies to Mycobacterium paratuberculosis
JP4934729B2 (ja)	2012-05-16	プロテーゼ感染の決定のための方法
CA1285222C (fr)	1991-06-25	Anticorps monoclonaux utiles pour l'identification de microorganismes agents causals des parodontopathies
JPH11133029A (ja)	1999-05-21	大腸菌ｏ１５７の分析方法及び分析用試薬
CA1310903C (fr)	1992-12-01	Diagnostic immunologique de l'infection gonococcique a l'aide d'un antigene de surface conserve de neisseria gonorrhoeae
US4582699A (en)	1986-04-15	Assay of immunoglobulin A protease and the rapid diagnosis of gonorrhea
BURNS et al.	1983	A preliminary evaluation of the Gonozyme® test
JPH02210263A (ja)	1990-08-21	微孔質膜を使用するクラミジア抗原または淋菌抗原の測定方法および診断試験キット
US6689572B1 (en)	2004-02-10	E. coli agglutination assay
AU602881B2 (en)	1990-11-01	Monoclonal antibodies useful in the identification of microorganisms causing peridontal disease